Andilum, Baby Girl .
HRN: 21-99-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2022
10/04/2022
IV
90mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes